anti-Minor Vault p193 Protein antibody product blog
Tags: Antibody; Monoclonal Antibody; Minor Vault p193 Protein; anti-Minor Vault p193 Protein antibody;
The Minor Vault p193 Protein n/a (Catalog #MBS609188) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Minor Vault p193 Protein (Vault Poly ADP-Ribose Polymerase, VPARP, PARP4, ADP-Ribosyltransferase (NAD+ Poly (ADP-Ribose) Polymerase)-like 1, ADPRTL1, H5 Proline Rich, I-alpha-I Related, KIAA0177, OTTHUMP00000042288, PARP Related/I-alpha-I Related H5/Proli reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Minor Vault p193 Protein can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC).Suitable for use in Western Blot, Immunocytochemistry and Immunohistochemstry.
Dilution: Immunohistochemistry (Paraformaldehyde (4%) fixed frozen): 1:10-1:20 Pretreat for 10 min with 20mM glycine in PBS, pH 7.5 and then for 10 min with 6N guanidine hydrochloride in 50mM Tris-HCl, pH 7.5.
Western Blot (ECL): 1:10-20. Researchers should empirically determine the suitability of the Minor Vault p193 Protein n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: pET28a(+) expression vector containing aa408-611 of the p193 cDNA. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Minor Vault p193 Protein are readily searchable from our website. Different antibodies against the same target such as Minor Vault p193 Protein may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.